openPR Logo
Press release

Next Generation Diabetes Therapy and Drug Delivery Market Scenario Indicates Prime Trends & Growth Parameters 2023

03-18-2019 05:14 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Next Generation Diabetes Therapy and Drug Delivery Market

The growth of the global next generation diabetes therapy and drug delivery market is driven by the surge in prevalence of diabetes worldwide, benefits of using next generation diabetes products over conventional ones, and the rise in disposable income leading to increased healthcare expenditure.

However, the high cost of products, lack of acute awareness among the populace, and less variability in products hamper market growth. Nonetheless, the development of affordable products with fewer side effects and the large undiagnosed diabetic patient population provide lucrative opportunities to emerging market players.

Get Sample Copy of Report @ https://www.alliedmarketresearch.com/request-sample/2098

The report states that the global next generation diabetes therapy and drug delivery market accounted for $617 million in 2015 and is projected to reach $9,673 Million by 2023, growing at a CAGR of 41.1% during the forecast period, 2016-2023.

Major Players:

• Sanofi
• Novo Nordisk
• MannKind Corporation
• Enteris BioPharma
• Dexcom Inc.
• Senseonics Holding Inc.
• Medtech
• Johnson & Johnson.

The report segments the global next generation diabetes therapy and drug delivery market by product type, demographic, indication, end user, and geography. Based on product type, the market is categorized into inhalable insulin, oral insulin, insulin patches, CGM systems, and artificial pancreas.

The GCM systems segment garnered the highest revenue in the global market in 2015, owing to its omnipresence in treating diabetes and is expected to continue its dominance throughout the forecast period. However, the artificial pancreas segment is anticipated to grow at the highest rate from 2016 to 2023. Based on demographics, the report bifurcates the market into child population (14 years).

The market is bifurcated into type 1 and type 2 diabetes based on the indication. Based on the end user, the report fragments the market into diagnostics/clinics, ICUs, and home healthcare. The diagnostics/clinics segment was the highest revenue contributor in 2015, accounting for about half of the global market shares. The segment is projected to maintain this trend throughout 2023, due to the increase in procurement of the products from diagnostics and clinics by diabetic patients.

Regionally, North America is expected to continue its market dominance throughout the forecast period. However, Asia-Pacific is poised to witness the highest growth, registering a CAGR of 50.2%, owing to rise in disposable income, improvement in healthcare expenditure, and an increase in adoption rate of advanced diabetic products.

Send Enquiry On Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2098

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Diabetes Therapy and Drug Delivery Market Scenario Indicates Prime Trends & Growth Parameters 2023 here

News-ID: 1658176 • Views: 199

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Based

AI Based Document Analyzer
Can Artificial Intelligence detect important paragraphs? Patodia Infotech Private Limited has developed an AI based solution that can highlight important paragraph according to its important. Let us take a scenario. You are a busy legal advisor (or a top executive in a big organization) and have received a 200-page document. You need to give your legal opinion or analysis for this document. You must read every word of the document
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Hospital-based EMR Market
Electronic medical record (EMR) is a digital version of a paper chart, which contains a patient's medical history. This system is designed to share information with other healthcare providers such as laboratories and specialists. It helps to reduce operational cost such as transcription services and overtime labor expenses. Get Sample PDF of Report@ https://www.alliedmarketresearch.com/request-toc-and-sample/3219 Increase in demand for advanced health monitoring systems drives the growth of the market. In addition, rise in
Plant Based Beverages Market
https://www.qandqmarketresearch.com/reports/7360187/plantbased-beverages-market-87 Plantbased products include plantbased beverages that are further classified into plantbased dairy alternatives, juices, and readytodrink beverages. The plantbased beverages segment is expected to witness a growing CAGR of 6.5% by 2025, owing to the changing eating habits of consumers. Consumers are more conscious about health and wellness than before, and want to consume products that are healthy and natural without compromising on the taste and flavor of the product. Increasing
Plant-based Snacks Market
https://www.qandqmarketresearch.com/reports/7287268/plantbased-snacks-market-24 Plantbased products are those products that are made entirely from plantbased ingredients, and limit or restrict any use of animalbased products. Plantbased products include plantbased snacks, which are further classified into meat alternative snacks, cereal/grainbased snacks, plantbased salted snacks, plantbased snack bars, and fruit and nut snacks. Based on regional segmentation for the plantbased snacks market, North America, Western Europe, and Asia Pacific are estimated to dominate the global plantbased
Account Based Marketing
Today, most of the marketing organizations are moving towards the Account Based Marketing ( ABM ) . The ABM approach has been there for years but the recent technologies available have made this approach scalable and hence more effective and popular. The traditional marketing approach has been around attracting your prospects from a larger pool. The account based marketing is about targeting accounts based on your best business connection. It is